Lazard Asset Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,248
| Closed | -$109K | – | 2633 |
|
|
2022
Q3 | $109K | Sell |
7,248
-629
| -8% | -$9.46K | ﹤0.01% | 1440 |
|
|
2022
Q2 | $59K | Buy |
+7,877
| New | +$59K | ﹤0.01% | 1743 |
|
|
2022
Q1 | – | Sell |
-3,048
| Closed | -$21K | – | 2614 |
|
|
2021
Q4 | $21K | Buy |
+3,048
| New | +$21K | ﹤0.01% | 2041 |
|
|
2021
Q2 | – | Sell |
-3,410
| Closed | -$60K | – | 2132 |
|
|
2021
Q1 | $60K | Sell |
3,410
-7,811
| -70% | -$137K | ﹤0.01% | 1371 |
|
|
2020
Q4 | $151K | Buy |
+11,221
| New | +$151K | ﹤0.01% | 1130 |
|